Torrent Pharma is in advanced talks with KKR to acquire JB Chemicals and Pharmaceuticals, reviving discussions from last year. The deal involves Torrent acquiring KKR’s 47.84% stake and launching an open offer, potentially leading to a Rs 20,734.61 crore buyout. This acquisition would bolster Torrent’s branded generics portfolio and provide entry into the CDMO business.
Fed tightening bets weigh on gold prices
Gold prices have taken a hit, influenced by rising oil rates that have sparked inflation fears and suggested further interest rate hikes may be on